Emergent BioSolutions (EBS) Other Non-Current Assets (2010 - 2026)
Emergent BioSolutions (EBS) posted Other Non-Current Assets of $11.0 million for Q2 2026, down 15.38% on a QoQ basis from $13.0 million in Q1 2026, and up 197.3% year-over-year from $3.7 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Other Non-Current Assets for 16 years, with the latest figure at $11.0 million in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 197.3% year-over-year to $11.0 million in Q2 2026; TTM through Jun 2026 was $11.0 million, a 197.3% increase from a year earlier, with the FY2025 full-year figure at $14.2 million, down 24.87% from the prior year.
- Other Non-Current Assets was $11.0 million for Q2 2026 at Emergent BioSolutions, down from $13.0 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $57.1 million in Q1 2022, with the low at $500000.0 in Q1 2024.
- Average Other Non-Current Assets over 4 years is $18.0 million, with a median of $11.6 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets plunged 60.08% in 2022, then jumped 640.0% in 2025.
- Over 4 years, Other Non-Current Assets stood at $40.8 million in 2022, then plunged by 53.68% to $18.9 million in 2024, then dropped by 24.87% to $14.2 million in 2025, then declined by 22.54% to $11.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $11.0 million (Q2 2026), $13.0 million (Q1 2026), and $14.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 9.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 6.38 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 5.50 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 109.58 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | 42.45 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 11.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.00 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 14.20 Mn |
| Sep 30, 2025 | 11.60 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | 18.90 Mn |
| Sep 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 500,000.00 |
| Sep 30, 2022 | 40.80 Mn |
| Jun 30, 2022 | 51.30 Mn |
| Mar 31, 2022 | 57.10 Mn |
| Dec 31, 2021 | 58.20 Mn |
| Sep 30, 2021 | 102.20 Mn |
| Jun 30, 2021 | 109.90 Mn |
| Mar 31, 2021 | 111.40 Mn |
| Dec 31, 2020 | 113.40 Mn |
| Sep 30, 2020 | 106.40 Mn |
| Jun 30, 2020 | 101.60 Mn |
API Access
Emergent BioSolutions Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();